San Jose, CA, United States of America

Timothy J Falla

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 36(Granted Patents)


Location History:

  • Vancouver, CA (2001)
  • San Jose, CA (US) (2008)

Company Filing History:


Years Active: 2001-2008

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Timothy J. Falla

Introduction

Timothy J. Falla is an accomplished inventor based in the United States. He has made significant contributions to the field of biomedicine, particularly in the development of peptides and small molecules aimed at protecting against cellular toxicity and treating skin conditions.

Latest Patents

Falla's latest patents include "Peptide Protection Against Ultraviolet Light Toxicity." This invention discloses short peptides that possess biological and therapeutic activity, specifically aimed at reducing or protecting against mutagen-induced cellular and tissue toxicity. The peptides are designed to protect against skin toxicity and mutagenesis resulting from ultraviolet (UV) light exposure. An example of such a peptide is Ser-Leu-Tyr-Gln-Ser (SEQ ID NO: 10). Additionally, he has developed "N-Acyl Amino Acid Derivatives For Treating Skin Conditions Such As Cellulite." This invention relates to small molecules with lipolytic and anti-adipogenic activity, which can be used to prevent or treat skin conditions like cellulite.

Career Highlights

Timothy J. Falla is currently associated with Helix Biomedix Inc., where he continues to innovate in the field of biomedicine. His work focuses on creating solutions that address significant health concerns related to skin toxicity and conditions.

Collaborations

Falla has collaborated with notable colleagues, including Lijuan Zhang and Scott M. Harris, to advance his research and development efforts.

Conclusion

Timothy J. Falla's contributions to the field of biomedicine through his innovative patents demonstrate his commitment to improving health outcomes. His work in peptide and small molecule development is paving the way for new therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…